newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC Deregistration

CHERRY HILL, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio" or "Company") (NASDAQ:VYNT) is a biotechnology company that incorporates innovative biology and data science to improve drug discovery